# Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori

> **NCT02693574** · PHASE4 · UNKNOWN · sponsor: **Damascus Hospital** · enrollment: 74 (actual)

## Conditions studied

- Helicobacter Pylori Gastrointestinal Tract Infection

## Interventions

- **DRUG:** Clarithromycin
- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT02693574
- **Lead sponsor:** Damascus Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12-01
- **Primary completion:** 2017-01-28
- **Final completion:** 2017-05-31
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2017-03-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02693574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02693574, "Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02693574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*